Skip Navigation


European Heart Journal Advance Access originally published online on February 6, 2009
European Heart Journal 2009 30(5):526-527; doi:10.1093/eurheartj/ehp028
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/5/526    most recent
ehp028v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McCullough, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCullough, P. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Treatment disparities in patients with acute coronary syndromes and kidney disease

Peter A. McCullough*

Department of Medicine, Divisions of Cardiology, Nutrition and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA

* Corresponding author. Tel: +1 248 655 5948; Fax: +1 248 655 5901, Email: pmc975@yahoo.com

This editorial refers to ‘Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction’{dagger}, by J.A. Wong et al. on page 549

The first 10% of the full text of this article appears below.

Management of acute coronary syndromes (ACS) has been considerably refined over the past several decades, with the advances in diagnostics including prompt electrocardiography, use of cardiac biomarkers including cardiac troponin, antiplatelet and antithrombotic agents, β-adrenergic blockers, statins, and targeted utilization of invasive management with coronary angiography and revascularization with percutaneous coronary intervention (PCI) in the majority, with amenable anatomy and coronary artery bypass surgery in a minority of patients with . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction
Jorge A. Wong, Shaun G. Goodman, Raymond T. Yan, Ron Wald, Alan J. Bagnall, Robert C. Welsh, Graham C. Wong, Jan Kornder, Kim A. Eagle, Philippe Gabriel Steg, Andrew T. Yan, and on behalf of the Canadian Acute Coronary Syndromes I and II, and Canadian Global Registry of Acute Coronary Events (GRACE/GRACE) Investigators
EHJ 2009 30: 549-557. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
V. Agrawal, B. Rai, J. Fellows, and P. A. McCullough
In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke
Nephrol. Dial. Transplant., November 27, 2009; (2009) gfp619v1.
[Abstract] [Full Text] [PDF]